A taRNA vaccine candidate induces a specific immune response that protects mice against Chikungunya virus infections

The arthritogenic alphavirus, chikungunya virus (CHIKV), is now present in almost 100 countries worldwide. Further spread is very likely, which raises public health concerns. CHIKV infections cause fever and arthralgia, which can be debilitating and last for years. Here, we describe a CHIKV vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Christin, Haefner, Erik, Gerbeth, Julia, Beissert, Tim, Sahin, Ugur, Perkovic, Mario, Schnierle, Barbara S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126847/
https://www.ncbi.nlm.nih.gov/pubmed/35664702
http://dx.doi.org/10.1016/j.omtn.2022.04.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126847/
https://www.ncbi.nlm.nih.gov/pubmed/35664702
http://dx.doi.org/10.1016/j.omtn.2022.04.036

Ejemplares similares